All News Roche Holding AG Deutsche Boerse AG

Equities

RHO5

CH0012032048

Delayed Deutsche Boerse AG Other stock markets 11:41:42 2019-06-28 am EDT			5-day change	1st Jan Change
245.6 ^EUR	-0.14%		-.--%	-.--%

07:29am	Roche's Lung-Cancer Drug Alecensa Gets New FDA Approval	DJ
07:28am	Roche's Early-stage Lung Cancer Treatment Alecensa Wins US FDA Nod	MT

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Roche's Lung-Cancer Drug Alecensa Gets New FDA Approval	01:29am	DJ
Roche's Early-stage Lung Cancer Treatment Alecensa Wins US FDA Nod	01:28am	MT
FDA Approves Genentech's Alecensa as First Adjuvant Treatment for People With ALK-Positive Early-Stage Lung Cancer	Apr. 18	BU
Roche's Genentech Gets FDA Approval for Lung-Cancer Treatment	Apr. 18	DJ
ROCHE HOLDINGS AG : UBS sticks Neutral	Apr. 18	ZD
Roche’s Multiple Sclerosis Injection Controls Relapses, Brain Lesions in Late-stage Trial	Apr. 17	MT
Roche: positive phase III results in MS	Apr. 17	CF
Genentech’s Subcutaneous Ocrevus One-Year Data Demonstrates Near-Complete Suppression of Clinical Relapses and Brain Lesions in Patients With Progressive and Relapsing Forms of MS	Apr. 17	BU
Roche Holding AG Announces Data from the Phase III OCARINA II Study (S31.006) of OCREVUS®? (ocrelizumab)	Apr. 17	CI
ROCHE HOLDINGS AG : JP Morgan reiterates its Sell rating	Apr. 15	ZD
Roche: positive phase III data in lymphoma	Apr. 15	CF
Roche's Late-stage Trial for Columvi Antibody Meets Primary Survival Endpoint in B-cell Lymphoma	Apr. 15	MT
Roche's Columvi Meets Main Goal in Lymphoma Phase 3 Trial	Apr. 15	DJ
Genentech’s Columvi Meets Primary Endpoint of Overall Survival in People With Relapsed or Refractory Diffuse Large B-Cell Lymphoma in Phase III STARGLO Study	Apr. 15	BU
ROCHE HOLDINGS AG : JP Morgan reaffirms its Sell rating	Apr. 12	ZD
Swiss Market Index Falls as ECB Signals June Rate Cut	Apr. 11	MT
ROCHE HOLDINGS AG : Berenberg reiterates its Neutral rating	Apr. 11	ZD
Roche: designation for Alzheimer's test	Apr. 11	CF
Roche, Eli Lilly Alzheimer's Blood Test to Get Expedited FDA Review	Apr. 11	DJ
Roche, Eli Lilly's Elecsys Blood Test Secures US FDA's Breakthrough Device Designation	Apr. 11	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ROCHE HOLDING : Q4 miss weighed heavily on the healthy 2024 guidance

February 01, 2024 at 07:42 am EST

Obesity: Roche joins the battle

December 04, 2023 at 10:48 am EST